Inter Pharma Public Company Limited(TH:IP)
฿4.90+0.04 (+0.82%)
TH:IP
Inter Pharma Public Company Limited financials statements
฿4.90
At close:+0.04 (+0.82%)
Inter Pharma Public Company Limited (IP) Ratios
Inter Pharma Public Company Limited Ratios
TH:IP's free cash flow for Q2 2026 was ฿1.95M. For the 2026 fiscal year, TH:IP's free cash flow was decreased by ฿-12.87M and operating cash flow was ฿14.82M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.73 | 1.87 | 2.51 | 3.04 | 1.99 |
| Quick Ratio | 1.17 | 1.24 | 1.78 | 2.39 | 1.43 |
| Cash Ratio | 0.44 | 0.35 | 0.86 | 1.56 | 0.52 |
| Solvency Ratio | 0.25 | 0.17 | 0.18 | 0.19 | 0.24 |
| Operating Cash Flow Ratio | 0.45 | 0.34 | 0.25 | 0.29 | -0.12 |
| Short-Term Operating Cash Flow Coverage | 1.59 | 1.32 | 1.21 | 1.18 | -0.25 |
| Net Current Asset Value | ฿ 166.09M | ฿ 115.40M | ฿ 368.20M | ฿ 562.97M | ฿ 123.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.13 | 0.14 | 0.18 | 0.27 |
| Debt-to-Equity Ratio | 0.19 | 0.20 | 0.21 | 0.28 | 0.47 |
| Debt-to-Capital Ratio | 0.16 | 0.17 | 0.17 | 0.22 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.08 | 0.10 | 0.14 | 0.20 |
| Financial Leverage Ratio | 1.57 | 1.56 | 1.54 | 1.57 | 1.74 |
| Debt Service Coverage Ratio | 1.26 | 1.09 | 1.47 | 1.50 | 0.83 |
| Interest Coverage Ratio | 8.76 | 3.81 | 4.25 | 7.36 | 18.20 |
| Debt to Market Cap | 0.11 | 0.16 | 0.14 | 0.15 | 0.10 |
| Interest Debt Per Share | 0.69 | 0.68 | 1.14 | 1.72 | 1.24 |
| Net Debt to EBITDA | 0.42 | 1.13 | -0.06 | -1.00 | 1.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.41% | 37.42% | 37.02% | 40.60% | 44.11% |
| EBIT Margin | 7.81% | 3.90% | 6.14% | 11.21% | 16.04% |
| EBITDA Margin | 13.14% | 9.76% | 11.66% | 15.53% | 18.97% |
| Operating Profit Margin | 7.81% | 3.98% | 6.14% | 11.27% | 16.04% |
| Pretax Profit Margin | 7.80% | 2.85% | 4.57% | 9.69% | 15.15% |
| Net Profit Margin | 5.58% | 1.96% | 2.85% | 7.80% | 11.58% |
| Continuous Operations Profit Margin | 6.20% | 1.99% | 3.31% | 8.36% | 12.17% |
| Net Income Per EBT | 71.50% | 68.91% | 62.42% | 80.54% | 76.42% |
| EBT Per EBIT | 99.86% | 71.62% | 74.38% | 85.96% | 94.45% |
| Return on Assets (ROA) | 3.78% | 1.23% | 1.72% | 3.93% | 7.93% |
| Return on Equity (ROE) | 5.94% | 1.92% | 2.65% | 6.17% | 13.81% |
| Return on Capital Employed (ROCE) | 6.59% | 3.03% | 4.42% | 6.79% | 14.70% |
| Return on Invested Capital (ROIC) | 4.84% | 1.98% | 3.03% | 5.56% | 10.10% |
| Return on Tangible Assets | 4.98% | 1.59% | 2.23% | 5.06% | 8.42% |
| Earnings Yield | 4.39% | 1.91% | 2.37% | 3.99% | 3.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.80 | 4.24 | 4.19 | 3.88 | 3.10 |
| Payables Turnover | 6.45 | 6.43 | 5.59 | 10.54 | 7.29 |
| Inventory Turnover | 3.83 | 3.60 | 3.19 | 2.77 | 2.71 |
| Fixed Asset Turnover | 1.81 | 1.65 | 1.92 | 1.93 | 1.99 |
| Asset Turnover | 0.68 | 0.63 | 0.60 | 0.50 | 0.68 |
| Working Capital Turnover Ratio | 4.75 | 3.22 | 2.05 | 2.26 | 3.09 |
| Cash Conversion Cycle | 114.75 | 130.75 | 136.33 | 191.26 | 202.21 |
| Days of Sales Outstanding | 75.99 | 86.08 | 87.10 | 93.97 | 117.78 |
| Days of Inventory Outstanding | 95.38 | 101.42 | 114.47 | 131.93 | 134.49 |
| Days of Payables Outstanding | 56.62 | 56.75 | 65.24 | 34.64 | 50.06 |
| Operating Cycle | 171.37 | 187.50 | 201.57 | 225.90 | 252.27 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.48 | 0.29 | 0.33 | 0.44 | -0.14 |
| Free Cash Flow Per Share | 0.24 | -0.14 | -0.06 | 0.28 | -0.96 |
| Dividend Paid and CapEx Coverage Ratio | 2.04 | 0.65 | 0.58 | 2.86 | -0.17 |
| Capital Expenditure Coverage Ratio | 2.04 | 0.68 | 0.84 | 2.86 | -0.17 |
| Operating Cash Flow Coverage Ratio | 0.72 | 0.45 | 0.30 | 0.27 | -0.12 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.09 | 0.07 | 0.09 | -0.05 |
| Free Cash Flow Yield | 5.28% | -4.29% | -1.06% | 3.12% | -7.96% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.00 | 52.27 | 41.07 | 25.31 | 33.33 |
| Price-to-Sales (P/S) Ratio | 1.27 | 1.03 | 1.20 | 1.96 | 3.86 |
| Price-to-Book (P/B) Ratio | 1.35 | 1.01 | 1.12 | 1.55 | 4.61 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 18.93 | -23.31 | -94.48 | 32.03 | -12.56 |
| Price-to-Operating Cash Flow Ratio | 9.63 | 10.96 | 17.64 | 20.84 | -84.40 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | -0.93 | -0.67 | 0.00 | 0.47 |
| Enterprise Value Multiple | 10.08 | 11.66 | 10.26 | 11.61 | 21.41 |
| Enterprise Value | 2.90B | 2.16B | 2.13B | 2.75B | 3.69B |
| EV to EBITDA | 10.08 | 11.66 | 10.26 | 11.61 | 21.41 |
| EV to Sales | 1.32 | 1.14 | 1.20 | 1.80 | 4.06 |
| EV to Free Cash Flow | 19.75 | -25.82 | -93.93 | 29.48 | -13.21 |
| EV to Operating Cash Flow | 10.05 | 12.14 | 17.54 | 19.18 | -88.78 |
| Tangible Book Value Per Share | 2.50 | 2.43 | 3.87 | 4.27 | 2.42 |
| Shareholders’ Equity Per Share | 3.40 | 3.20 | 5.14 | 5.88 | 2.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.30 | 0.28 | 0.13 | 0.20 |
| Revenue Per Share | 3.62 | 3.13 | 4.78 | 4.65 | 3.11 |
| Net Income Per Share | 0.20 | 0.06 | 0.14 | 0.36 | 0.36 |
| Tax Burden | 0.71 | 0.69 | 0.62 | 0.81 | 0.76 |
| Interest Burden | 1.00 | 0.73 | 0.74 | 0.86 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.33 | 0.34 | 0.32 | 0.30 | 0.29 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.36 | 3.29 | 2.39 | 0.97 | -0.30 |
Currency in THB
